Plain-English explainer
Wegovy Constipation & Diarrhea: Managing GI Side Effects
We keep this plain-English — no jargon, every claim sourced.
If you are starting Wegovy, the side effects you are most likely to run into are not dramatic or dangerous — they are gut symptoms: constipation, diarrhea, and nausea. These are by far the most common complaints, they are usually mild to moderate, and they tend to fade as your body adjusts. This guide explains, honestly, why they happen, how common they actually are in the trials, and the practical, evidence-grounded steps that help. None of this replaces your prescriber's advice — but knowing what is normal versus what is a red flag makes the first weeks a lot less stressful.
A grounding fact first: Wegovy is semaglutide, a GLP-1 receptor agonist. It works largely by slowing gastric emptying — food leaves your stomach more slowly — and by acting on appetite signaling in the brain45. That slowed gut transit is exactly why GLP-1 medicines reduce hunger and portion size, and it is also the direct mechanical reason the side effects are gastrointestinal. The same property that makes the drug work is the one that can make your gut grumble — and it is also why some people get extra burping and reflux, which we cover in "Ozempic burps" & acid reflux.
How common are GI side effects, really?
Common — but not universal, and rarely severe. In Wegovy's FDA prescribing information, the gastrointestinal adverse reactions reported in the weight-management trials were, versus placebo, nausea (about 44%), diarrhea (about 30%), and constipation (about 24%), along with vomiting and abdominal pain8. Those are real numbers, but two points temper them: most cases were mild to moderate, and they were most frequent during dose escalation — the period when the dose is being stepped up — then generally eased over time8.
The phase-3 trials tell the same story. In STEP 1 (semaglutide 2.4 mg in adults with overweight or obesity without diabetes), GI events were the most common adverse effects, were typically transient, and were the main reason a minority of participants discontinued1. In STEP 2 (adults with type 2 diabetes), the pattern held — gastrointestinal disorders led the side-effect profile and were generally mild to moderate2. So if you feel queasy or backed up in week two, you are squarely in the expected, well-documented range — not an outlier.
Why the dose goes up slowly (and why that matters here)
The whole reason Wegovy is titrated — started at a low 0.25 mg and stepped up roughly every four weeks over about 16–20 weeks — is to limit these GI side effects. Each escalation is the point at which symptoms are most likely to flare, which is also why jumping the dose too fast tends to backfire. Slow and steady is not bureaucratic caution; it is the single most evidence-supported tactic for tolerability3. If a given step is rough, prescribers can hold you at the current dose longer before going up — a standard, legitimate adjustment, not a failure. For how the full ladder works, see our semaglutide dosing and side effects guide.
Managing constipation
Constipation comes from slowed gut motility plus, often, simply eating and drinking less. Practical, low-risk measures that clinicians commonly recommend for GLP-1 users:
- Fluids first. Eating less often means drinking less without noticing. Steady water intake through the day is the simplest lever.
- Fiber, gradually. More vegetables, fruit, whole grains, and legumes — added slowly so you do not trade constipation for bloating. A bulk-forming or osmotic over-the-counter laxative can help, but clear it with your prescriber or pharmacist first.
- Move. Regular physical activity supports normal bowel function.
These align with the practical management guidance for GLP-1 GI effects in the clinical literature6. The bigger picture of how to eat on the drug — protein first, fiber ramped up gently, steady hydration, small slow meals — is laid out in what to eat on Wegovy. If constipation is severe, persistent, or paired with significant abdominal pain or vomiting, that is a call-your-prescriber situation, not a tough-it-out one.
Managing diarrhea
Diarrhea is the flip side and, for some people, shows up instead of (or alongside) constipation. Helpful approaches:
- Hydrate to replace losses — water, and where appropriate fluids with electrolytes — since diarrhea can dehydrate you.
- Ease off the usual triggers — very greasy, fried, or heavily spiced meals, and for some people large amounts of caffeine or sugar alcohols.
- Smaller, plainer meals during a flare are gentler than large rich ones.
Diarrhea, like the other GI effects, is usually mild and tends to settle as you adjust68. Watch for dehydration (dizziness, very dark urine, marked thirst) — and note that dehydration is the pathway by which GLP-1 GI side effects can stress the kidneys, which is why staying hydrated is more than comfort advice8. We unpack that organ-specific risk, alongside the gallbladder signal, in semaglutide and your gallbladder/kidneys.
Managing nausea (the most common one)
Nausea tops the list, and the practical playbook is well established: eat smaller portions, stop at the first sign of fullness, eat slowly, and favor blander, lower-fat foods while easing up on very rich or greasy meals6. Because the drug slows stomach emptying, overeating or piling on fatty food is precisely what provokes nausea — so the medicine is, in a sense, nudging you toward the eating pattern that also reduces the side effect. Most people find nausea worst right after a dose increase and improving within days to a couple of weeks.
What is normal vs. when to call your prescriber
Normal vs. call-your-prescriber
- Normal: nausea, constipation, or diarrhea that is mild to moderate — worst right after a dose increase, then easing over days to weeks.
- Normal: GI symptoms that settle as you adjust between dose steps (they are expected; the drug works even without them).
- Call your prescriber: severe or persistent abdominal pain, especially if it radiates to your back — a possible pancreatitis signal.
- Call your prescriber: inability to keep fluids down, or signs of dehydration (dizziness, very dark urine, marked thirst) — dehydration can stress kidneys.
- Call your prescriber: symptoms that are not easing after several weeks at a stable dose, or that are severe enough to disrupt daily life.
Mild, dose-escalation-linked nausea, constipation, or diarrhea that improves over days to weeks is the expected course. Seek medical advice promptly, however, for warning signs that go beyond ordinary GI upset — for example severe or persistent abdominal pain (especially if it radiates to the back, with or without vomiting, a possible signal of pancreatitis), signs of dehydration, or inability to keep fluids down8. These are uncommon, but they are the symptoms worth taking seriously rather than waiting out. When in doubt, ask — that is what the prescribing relationship is for.
A note on compounded and grey-market semaglutide
Every figure above comes from trials and the FDA label for FDA-approved, standardized Wegovy8. Compounded semaglutide from some telehealth and med-spa sources is a different situation: dose accuracy and formulation can vary, titration may be looser, and the tidy "side effects ease during a slow ramp" expectation does not automatically transfer. Products from unregulated online sellers are riskier still. If you are weighing where to get semaglutide, our best semaglutide providers guide compares options on price and oversight, and the pillar Semaglutide: How It Works, Results & Side Effects lays out the full evidence picture.
The honest bottom line
Constipation, diarrhea, and nausea are Wegovy's most common side effects, they cluster around dose increases, and for most people they are mild to moderate and temporary18. The most powerful tool against them is the slow titration the drug is designed around; the rest is sensible self-care — hydration, gradual fiber, smaller and plainer meals, eating slowly6. Keep an eye out for the genuine red flags, loop in your prescriber rather than self-adjusting the dose, and remember this is general education, not medical advice for your specific situation. For what to expect on the scale while you ride out the early weeks, see when does Wegovy start working?. And because alcohol is itself a gut irritant that can amplify nausea on a drug that already slows the stomach, it is worth reading whether you can drink alcohol on Wegovy or Ozempic.
A few more quick ones
What are the most common side effects of Wegovy?
Gastrointestinal symptoms. In the trials and FDA label, the most common were nausea (about 44%), diarrhea (about 30%), and constipation (about 24%) versus placebo, along with vomiting and abdominal pain. Most cases were mild to moderate and clustered around dose increases.
Does Wegovy cause constipation or diarrhea?
It can cause either. Wegovy slows gastric emptying, which for some people means constipation and for others diarrhea; some experience both at different times. Both are usually mild and tend to ease as the body adjusts. Hydration, gradual fiber, and smaller, plainer meals help.
How long do Wegovy GI side effects last?
For most people they are worst right after a dose increase and improve over days to a couple of weeks as the body adjusts. They are most frequent during the roughly 16 to 20 week titration period and generally settle once you reach a stable maintenance dose.
How can I reduce nausea on Wegovy?
Eat smaller portions, stop at the first sign of fullness, eat slowly, and favor blander, lower-fat foods while easing up on very rich or greasy meals. Because the drug slows stomach emptying, overeating and fatty meals are the main triggers for nausea.
When should I call my doctor about Wegovy side effects?
Seek prompt advice for severe or persistent abdominal pain (especially radiating to the back, a possible pancreatitis signal), signs of dehydration, or being unable to keep fluids down. Mild nausea, constipation, or diarrhea that improves over days to weeks is expected.
Where this comes from
Every claim above traces back to one of these — real studies and official labeling.
- Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1).. N Engl J Med. https://pubmed.ncbi.nlm.nih.gov/33567185/
- Davies M, Færch L, Jeppesen OK, et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial.. Lancet. https://pubmed.ncbi.nlm.nih.gov/33667417/
- Sorli C, Harashima SI, Tsoukas GM, et al. (2017). Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial.. Lancet Diabetes Endocrinol. https://pubmed.ncbi.nlm.nih.gov/28110911/
- Drucker DJ (2022). GLP-1 physiology informs the pharmacotherapy of obesity.. Mol Metab. https://pubmed.ncbi.nlm.nih.gov/34626851/
- Friedrichsen M, Breitschaft A, Tadayon S, et al. (2021). The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity.. Diabetes Obes Metab. https://pubmed.ncbi.nlm.nih.gov/33269530/
- Wharton S, Davies M, Dicker D, et al. (2022). Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice.. Postgrad Med. https://pubmed.ncbi.nlm.nih.gov/34775881/
- Rubino D, Abrahamsson N, Davies M, et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial.. JAMA. https://pubmed.ncbi.nlm.nih.gov/33755728/
- Novo Nordisk Pharmaceutical Industries, LP (2026). WEGOVY (semaglutide) injection — FDA Prescribing Information (DailyMed).. DailyMed (NLM), FDA label. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Keep exploring
Semaglutide: How It Works, Results & Side Effects
A plain-English, fully-sourced guide to semaglutide — how it works, what the trials show for weight and blood sugar, dosing, side effects, and ongoing use.
ReadOral vs Injectable Semaglutide: What's the Difference?
Semaglutide comes as a daily tablet (Rybelsus) and a weekly injection (Ozempic, Wegovy). A plain-English, sourced look at how they differ.
ReadSemaglutide Dosing & Side Effects: A Plain Guide
How semaglutide is titrated from 0.25 mg upward, why the slow start matters, and how to manage common GI side effects — sourced to the FDA label and trials.
ReadWhat Happens If You Stop Semaglutide?
The honest, evidence-based answer: most people regain weight after stopping semaglutide. What STEP 1 and STEP 4 show about ongoing therapy.
ReadHow Do You Inject Wegovy? Step-by-Step (Pen & Vial)
A friendly, label-sourced walkthrough of injecting Wegovy — pen and vial — covering sites, technique, the dose schedule, storage, and sharps disposal.
Read"Ozempic Face": Why It Happens & What Helps
"Ozempic face" is facial volume loss from rapid weight loss, not a drug toxicity. Here's the real anatomy behind it and the evidence-based ways to soften it.
ReadOzempic vs Wegovy: Same Drug, Different Label
Ozempic and Wegovy are both semaglutide — the same molecule. What differs is the FDA-approved use, the maximum dose, and insurance coverage. Honest breakdown.
ReadRybelsus (Oral Semaglutide): Does the Pill Work for Weight Loss?
Rybelsus is the semaglutide pill — but it's FDA-approved for type 2 diabetes, not weight loss. An honest, sourced look at what the PIONEER trials actually show.
ReadWhere's the Best Place to Inject Semaglutide?
Abdomen, thigh, or arm? A label- and trial-sourced guide to where to inject semaglutide (Wegovy/Ozempic), why rotation matters, and what to avoid.
ReadDoes Wegovy Need to Be Refrigerated? A Plain-English Storage Guide
Yes, Wegovy is refrigerated — but there's a room-temperature window, a hard no on freezing, and travel rules. Here's exactly how to store it, per the FDA label.
ReadWhen Does Wegovy Start Working? A Realistic Timeline
Wegovy starts blunting appetite within days, but real weight loss is a slow curve over months. Here's an honest, trial-backed timeline of what to expect.
ReadCan You Drink Alcohol on Wegovy or Ozempic?
No formal alcohol ban on semaglutide, but real interactions matter: hypoglycemia, worse nausea, and a curious appetite-for-alcohol effect. Honest guide.
ReadSemaglutide & Your Gallbladder / Kidneys: A Risk Check
Does semaglutide harm your gallbladder or kidneys? An honest, label-and-trial-based look at gallstone risk and the dehydration-driven kidney concern.
ReadWegovy Cost, GoodRx & the Cheapest Ways Without Insurance
What Wegovy costs in 2026 — list price, NovoCare self-pay vials, the savings card, GoodRx discounts, and the honest truth on compounded semaglutide.
ReadDoes Insurance Cover Wegovy or Ozempic? An Honest Guide
Whether insurance covers Wegovy or Ozempic hinges on the diagnosis, not the drug. Ozempic-for-diabetes is covered far more often than Wegovy-for-weight-loss.
ReadDo Wegovy & Ozempic Protect the Heart? (The SELECT Trial)
Semaglutide cut major cardiovascular events 20% in the SELECT trial — but only in a specific population. What the heart data does and doesn't prove.
ReadSwitching From Zepbound to Wegovy (and Back): An Honest Guide
Tirzepatide and semaglutide are different molecules — the doses are NOT 1:1. What an evidence-led, clinician-led switch actually involves, and why.
ReadWegovy Reviews: What Real Users (and the Trials) Report
An honest synthesis of Wegovy reviews — what users commonly say about results, side effects and plateaus, weighed against the STEP and SELECT trial data.
Read"Ozempic Burps" & Acid Reflux: Why It Happens & What Helps
Why semaglutide causes sulfur-smelling burps, reflux and heartburn — the gastric-emptying mechanism, how common it is, and evidence-based ways to manage it.
ReadDoes Wegovy or Ozempic Raise Heart Rate? (Palpitations Explained)
Semaglutide modestly raises resting heart rate — a labeled, class effect of a few bpm. Why it happens, what palpitations mean, and when to seek care.
ReadDoes Semaglutide Cause Hair Loss? (And Does It Grow Back?)
Hair loss hit about 3% on Wegovy in trials — almost always temporary shedding from rapid weight loss, not the drug. What the evidence says, and if it regrows.
ReadWill Semaglutide Make You Lose Muscle?
Some weight lost on semaglutide is muscle — but that is true of almost all weight loss, not a drug-specific effect. Protein and resistance training help.
ReadWhat to Eat on Wegovy: A Semaglutide Food Guide
A practical, honest food guide for Wegovy and semaglutide — protein first, fiber, hydration, small portions, and the foods most likely to trigger nausea.
Read